Variant report
Variant | esv3516269 |
---|---|
Chromosome Location | chr8:60985447-61009090 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RAB2A-1 | chr8:60987153-60987282 | XLOC_006814 |
2 | lnc-RAB2A-1 | chr8:60987153-60987274 | ENSG00000254775 |
3 | lnc-RAB2A-1 | chr8:60987153-60987282 | NONHSAT126813 |
4 | lnc-RAB2A-1 | chr8:60987153-60987353 | XLOC_006814 |
No data |
No data |
Variant related genes | Relation type |
---|---|
HNRNPA2B1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144595095 | chr8:60985465-60985466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs562102865 | chr8:60985497-60985498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368770470 | chr8:60985510-60985511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182563944 | chr8:60985534-60985535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562945226 | chr8:60985543-60985544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs533585412 | chr8:60985549-60985550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186613410 | chr8:60987158-60987159 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs555652778 | chr8:60987180-60987181 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs567553989 | chr8:60987239-60987240 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs552377143 | chr8:60987292-60987293 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs538273060 | chr8:60987319-60987320 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs148129196 | chr8:60987331-60987332 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs191151080 | chr8:60987412-60987413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73684951 | chr8:60987416-60987417 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs73257569 | chr8:60987477-60987478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542836930 | chr8:60987497-60987498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2688654 | chr8:60987518-60987519 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs531879086 | chr8:60987521-60987522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186841452 | chr8:60987573-60987574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11305149 | chr8:60987584-60987585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73684952 | chr8:60987602-60987603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559167900 | chr8:60987607-60987608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs59278405 | chr8:60987610-60987611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532718242 | chr8:60987653-60987654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570315065 | chr8:60987681-60987682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566413394 | chr8:60987706-60987707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527517626 | chr8:60987769-60987770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548885901 | chr8:60987802-60987803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567612760 | chr8:60987831-60987832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34493532 | chr8:60987883-60987884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538129185 | chr8:60987884-60987885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192932301 | chr8:60987940-60987941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571672025 | chr8:60987976-60987977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190421532 | chr8:60988400-60988401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375799920 | chr8:60988443-60988444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561073498 | chr8:60988444-60988445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143039538 | chr8:60988493-60988494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550122097 | chr8:60988521-60988522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs571532987 | chr8:60988524-60988525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs539050990 | chr8:60988608-60988609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs113113020 | chr8:60988619-60988620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547471938 | chr8:60988638-60988639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566205104 | chr8:60988640-60988641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs370181166 | chr8:60988645-60988646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs55730968 | chr8:60988653-60988654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2688653 | chr8:60988669-60988670 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs193058608 | chr8:60988698-60988699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs56867466 | chr8:60988715-60988716 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs7812852 | chr8:60988721-60988722 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs577591799 | chr8:60988722-60988723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Schizophrenia | 23813976 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:60985200-60985600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr8:60987400-60987800 | Enhancers | Primary B cells from cord blood | blood |
3 | chr8:60987400-60988000 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr8:60988400-60988800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:60988400-60989000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr8:60994600-60995600 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr8:60994800-60995600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr8:60995000-60995600 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
9 | chr8:61001200-61001600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr8:61001600-61002600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr8:61002600-61002800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr8:61002600-61002800 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr8:61002800-61003400 | Weak transcription | Colon Smooth Muscle | Colon |
14 | chr8:61003200-61004800 | Enhancers | Rectal Smooth Muscle | rectum |
15 | chr8:61003400-61004400 | Enhancers | Colon Smooth Muscle | Colon |